Physician profile
Kyle A Rogers
NPI 1750760609
$19,161.72
in general payments reported to CMS, 2019-2025
14 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.58 · 2020: $62.70 · 2021: $81.29 · 2022: $6,478 · 2023: $12K · 2024: $150 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,752 · Consulting Fee: $4,752 · Travel and Lodging: $2,283 · Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,752.00 |
| Consulting Fee | $4,752.00 |
| Travel and Lodging | $2,282.76 |
| Food and Beverage | $740.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $18,473.22 | 2022-2023 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Alcon Vision LLC | $311.63 | 2020-2025 | Clareon, Argos |
| Astellas Pharma US INC | $77.40 | 2024-2025 | Izervay |
| Abbvie INC. | $49.31 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $47.51 | 2021 | |
| Harrow Eye, LLC | $41.37 | 2024-2025 | Vevye, Triesence |
| Glaukos Corporation | $32.05 | 2025 | Idosetr |
| Omeros Corporation | $26.32 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $21.89 | 2021 | |
| Merz North America, INC. | $18.74 | 2020 | |
| Bausch & Lomb Americas INC. | $18.25 | 2023 | Stellaris |
| Tarsus Pharmaceuticals, INC. | $17.55 | 2025 | Xdemvy |
| Sight Sciences, INC. | $14.59 | 2020 | |
| Allergan, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.